Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace.
Despite all the attention that Amazon justifiably receives for the transformational effect it is exerting on mass market retailing, a case can be made that the company that is in the best position to meet the omnichannel needs of consumers over the long term is Walmart.
Pharmacies and grocery stores are better positioned than doctors to promote healthy behavior and prevent debilitating and costly illnesses. Many executives know this, but it is surprising how many acknowledge they have not done much about it.
To address the personal forms of value that tomorrow’s consumers will demand, consumer packaged goods companies need to move from “idle” to “agile.” Chain drug stores are uniquely positioned to help.
For the better part of a decade, Walgreens Boosts Alliance has been engaged in continually rethinking what a chain drug store means to the consumer, and how the format needs to evolve to remain relevant in an era when digital technology is changing the rules of the game in retailing and health care.
On October 27 the Drug Enforcement Agency (DEA) will hold its 14th National Consumer Drug Take-Back Day. The event will be well publicized and will enable the safe and secure disposal of millions of pounds of expired and unneeded prescription medications.
A little over 40 years ago, the first issue of Chain Drug Review appeared.
The appointment of Jim Donald to succeed Bob Miller as chief executive officer of Albertsons Cos. earlier this month symbolizes the company’s ability to maintain its equilibrium when confronted with adversity and find new ways forward.
creating greater and greater financial challenges for retail pharmacies. In the second quarter of 2018, DIR accounted for 1.13% of sales and, year-to-date, it is trending at 1% of sales. For the same period last year, DIR was running at 0.9% of sales. On top of
Last month investment firm Piper Jaffray projected Amazon will more than triple its advertising business to some $16 billion by 2021, largely based on the retail giant’s position as “the world’s largest product search engine.
those born between 1981 and 1997 — will represent the largest and most influential adult generational cohort in America, with a profound opportunity to realign the nation’s priorities as they enter their prime years and influence the shape of the future health care landscape. Millennials
The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern.
The who, why, what, where and how of health care retail are changing faster and more dramatically than for perhaps any segment of consumer packaged goods.
Retail in the future will look nothing like what we see today. A new role for physical retailers is long overdue, and only a few have satisfied the need for change.
which is not news. It is up to you to determine how you will service their evolved expectations. They engage with their social communities online, complete tasks on the go and transact all via their mobile
There’s never been a more critical time to start turning your shoppers into pharmacy customers. With the 900-pound gorilla, Amazon.
